Importance of Prospective Studies in Pregnant and Breastfeeding Women Living With Human Immunodeficiency Virus

Recently, the US Food and Drug Administration and European Medicines Agency issued warnings on the use of dolutegravir and darunavir/cobicistat for treatment of pregnant women living with human immunodeficiency virus (HIV). It took 3–5 years to identify the risks associated with the use of these ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Colbers, Angela, Mirochnick, Mark, Schalkwijk, Stein, Penazzato, Martina, Townsend, Claire, Burger, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Viewpoints
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743813/
https://www.ncbi.nlm.nih.gov/pubmed/30783649
http://dx.doi.org/10.1093/cid/ciz121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743813/
https://www.ncbi.nlm.nih.gov/pubmed/30783649
http://dx.doi.org/10.1093/cid/ciz121

Ejemplares similares